Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Revenue (2017 - 2025)

Assembly Biosciences (ASMB) has 8 years of Revenue data on record, last reported at $10.8 million in Q3 2025.

  • For Q3 2025, Revenue rose 57.62% year-over-year to $10.8 million; the TTM value through Sep 2025 reached $37.2 million, up 31.3%, while the annual FY2024 figure was $28.5 million, 298.16% up from the prior year.
  • Revenue reached $10.8 million in Q3 2025 per ASMB's latest filing, up from $9.6 million in the prior quarter.
  • Across five years, Revenue topped out at $10.8 million in Q3 2025 and bottomed at $5.8 million in Q1 2024.
  • Average Revenue over 4 years is $8.0 million, with a median of $7.4 million recorded in 2024.
  • Peak YoY movement for Revenue: tumbled 81.93% in 2021, then surged 62.82% in 2025.
  • A 4-year view of Revenue shows it stood at $6.3 million in 2021, then increased by 14.53% to $7.2 million in 2023, then increased by 2.71% to $7.4 million in 2024, then surged by 46.65% to $10.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $10.8 million in Q3 2025, $9.6 million in Q2 2025, and $9.4 million in Q1 2025.